The increased glial activation could be the consequence of exaggerated diabetes-induced neuronal damage, in addition to IL-33 deficiency-mediated dysregulated retinal immune regulation. The gene discussed is IL33; the disease is hyperinsulinemic hypoglycemia, familial, 4.